Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 2/3 1

Status

Unknown 4Completed 4Recruiting 3Terminated 2Not yet recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Uterine Neoplasms 1Thymoma 1Thymic epithelial tumor 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Terminated × TP protocol × Clear all
NCT00582205 2021-05-19

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

University of Oklahoma

Phase 2 Terminated
21 enrolled 7 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT00818090 2013-04-12

Paclitaxel and Cisplatin for Thymic Neoplasm

Korean Cancer Study Group

Phase 2 Terminated
39 enrolled
Thoracic

Thymic epithelial tumor, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡